window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech

  • Biotech,Cell & Gene Therapy,Clinical Development,Clinical Trials,European biotech,Opthalmology

    PulseSight completes Phase 1 dosing of gene therapy candidate PST-611 in dry AMD and geographic atrophy

    PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

    January 26, 2026
  • Biotech,Drug Development,Partnerships & Funding,Rare Diseases,Technology and platforms

    Mendra launches with $82 million Series A to develop rare disease therapies

    Mendra, Inc. has launched with the closing of an $82 [...]

    January 23, 2026
  • Biotech,Drug Development,Global health,Partnerships & Funding,RNA Therapeutics

    Hongene Biotech receives Gates Foundation grant for patent-free mRNA cap analogs

    Hongene Biotech has received a grant from the Gates Foundation [...]

    January 22, 2026
  • Biotech,Drug Development,Immunology,Partnerships & Funding,Research & Development

    Resolve M Therapeutics exits stealth with pro-resolution immunology platform concept

    Resolve M Therapeutics has announced its exit from stealth as [...]

    January 22, 2026
  • Artificial Intelligence,Biotech,Clinical Trials,Diagnostics,Oncology,Precision medicine,Research & Development,Technology and platforms

    SpotitEarly announces strategic partnership with Fox Chase Cancer Center to advance early cancer detection

    SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

    January 21, 2026
  • Biotech,Cell & Gene Therapy,Drug Development,Events and Conferences

    ELRIG announces keynotes for inaugural Cell and Gene Therapy 2026 conference

    ELRIG has unveiled the keynote speakers for its inaugural Cell [...]

    January 26, 2026
  • Biotech,Clinical Trials,Funding,Pharmaceuticals and therapeutics

    Infinitopes raises $35 million seed round to advance precision cancer vaccine

    Infinitopes, a clinical-stage biotech developing precision cancer vaccines, has completed [...]

    January 21, 2026
  • Biotech,Central Nervous System,Clinical Development,Clinical Trials,Pharmaceuticals and therapeutics,Rare Diseases

    Exciva raises €51 million Series B to fund phase 2 Alzheimer’s agitation trial

    Exciva GmbH has raised €51 million ($59m) in a Series [...]

    January 20, 2026
  • Biotech,CDMOs & Manufacturing,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

    Syngene International has extended its strategic collaboration with Bristol Myers [...]

    January 19, 2026
  • Biotech,CDMOs & Manufacturing,Drug Development,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Onyx Scientific expands material science capabilities as part of 25th anniversary milestone

    Onyx Scientific has expanded its solid form and material science [...]

    January 19, 2026
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption
    Categories: Clinical Development, Clinical Trials, Data Management, Global health, Real world evidence
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top